Recall of Azathioprine lot 558470A

[Mike Bartolatz]

Subject: [JRA] Nationwide Recall of a single manufacturing lot of Azathioprine tablets, 50 mg


MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Roxane Laboratories and FDA notified pharmacists and other healthcare
professionals of a nationwide recall of a single manufacturing lot of
Azathioprine tablets, 50 mg (Lot 558470A, Exp Mar 2009) used to help
prevent rejection in kidney transplant patients, and to manage severe
rheumatoid arthritis.

The recall was initiated due to concerns that
bottles from this single lot # 558470A, labeled as Azathioprine may
contain Methotrexate, 2.5 mg tablets.

Information has been sent to
pharmacists alerting them of the details pertaining to this recall.
Pharmacists who may have dispensed Azathioprine tablets to patients from
manufacturing lot 558470A are instructed to contact those patients to
assure they did not inadvertently receive Methotrexate tablets.

Read the complete MedWatch 2006 Safety summary, including a link to the
firm press release, at:

http://www.fda.gov/medwatch/safety/2006 ... othioprine



__._,_.___
Messages in this topic (1) Reply (via web post) | Start a new topic
Messages | Files | Photos | Links | Database | Polls | Calendar